Endonovo Therapeutics

About:

Endonovo Therapeutics is a biotechnology company developing off-the-shelf regenerative products.

Website: http://endonovo.com/

Twitter/X: endonovo

Description:

Endonovo Therapeutics is a biotechnology company developing off-the-shelf regenerative products that no longer require the injection of stem cells. Its platform, Cell Free Therapeutics, harnesses the biological secretions of cells to create therapies that can be immediately administered following injuries or to treat acute and chronic diseases. Its second platform is the development of non-invasive, bioelectronics to stimulate the body's natural repair system to treat injuries and inflammatory diseases.

Total Funding Amount:

$15.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Woodland Hills, California, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)endonovo.com

Founders:

Alan Collier

Number of Employees:

11-50

Last Funding Date:

2016-11-30

IPO Status:

Public

Industries:

© 2025 bioDAO.ai